Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia

Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia

Background and Purpose: Thrombophilic gene alterations are a major risk factor for cerebral sinus vein thrombosis (CSVT). Up to 30% of all patients with cerebral sinus vein thrombosis (CSVT) are found to have thrombophilic defects such as prothrombin mutation (PTM) or factor V Leiden (FVL). Their re...

Full description

Bibliographic Details
Main Authors: Lukas Kellermair, Matthias W. G. Zeller, Caterina Kulyk, Josef Tomasits, Tim J. von Oertzen, Milan R. Vosko
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Life
Subjects:
cerebral sinus vein thrombosis
dabigatran peak concentration
factor II mutation
factor V Leiden
thrombus dissolution
Online Access:https://www.mdpi.com/2075-1729/12/7/970

Internet

https://www.mdpi.com/2075-1729/12/7/970

Similar Items